![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Nosch Labs Private Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their significant offerings is Quetiapine Fumarate, Unit-IV, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2018-160 - Rev 02
This Chemical Type CEP, issued on June 17, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2541 associated with this CEP further emphasizes